{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:20:41Z","timestamp":1793524841744,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1 233330"],"award-info":[{"award-number":["UG1 233330"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180822"],"award-info":[{"award-number":["U10CA180822"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180868"],"award-info":[{"award-number":["U10CA180868"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA098252"],"award-info":[{"award-number":["P50 CA098252"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.annonc.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:08:51Z","timestamp":1757768931000},"page":"1514-1524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology\/GOG-263\/KGOG 1008"],"prefix":"10.1016","volume":"36","author":[{"given":"S.Y.","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-J.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mayadev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Heugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-H.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2389-6757","authenticated-orcid":false,"given":"J.H.","family":"No","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.","family":"Mannel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8260-5403","authenticated-orcid":false,"given":"D.","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1073-8688","authenticated-orcid":false,"given":"D.M.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"W.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-6845","authenticated-orcid":false,"suffix":"III","given":"C.A.","family":"Leath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Monk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.annonc.2025.09.003_bib1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","article-title":"NCCN Guidelines(R) Insights: Cervical Cancer, Version 1.2024","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.annonc.2025.09.003_bib2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ijgc-2021-002921","article-title":"ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer","volume":"31","author":"Schmeler","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.annonc.2025.09.003_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa2308900","article-title":"Simple versus radical hysterectomy in women with low-risk cervical cancer","volume":"390","author":"Plante","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.annonc.2025.09.003_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.annonc.2025.09.003_bib5","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"issue":"2 Pt 1","key":"10.1016\/j.annonc.2025.09.003_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0090-8258(81)90145-1","article-title":"Prognostic factors in stage I carcinoma of the cervix","volume":"12","author":"Boyce","year":"1981","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.annonc.2025.09.003_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0090-8258(90)90072-S","article-title":"Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study","volume":"38","author":"Delgado","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"suppl 2","key":"10.1016\/j.annonc.2025.09.003_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/1097-0142(19810715)48:1+<560::AID-CNCR2820481320>3.0.CO;2-T","article-title":"Prognostic factors in cervical carcinoma: implications in staging and management","volume":"48","author":"Rotman","year":"1981","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.annonc.2025.09.003_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0090-8258(89)90070-X","article-title":"A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study","volume":"35","author":"Delgado","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.annonc.2025.09.003_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.annonc.2025.09.003_bib11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2009.11.019","article-title":"Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors?","volume":"79","author":"Ryu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.annonc.2025.09.003_bib12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2018.10.018","article-title":"Surgical treatment of \u201cintermediate risk\u201d lymph node negative cervical cancer patients without adjuvant radiotherapy\u2014a retrospective cohort study and review of the literature","volume":"151","author":"Cibula","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.annonc.2025.09.003_bib13","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.3802\/jgo.2020.31.e35","article-title":"Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor","volume":"31","author":"Kim","year":"2020","journal-title":"J Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.annonc.2025.09.003_bib14","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/jog.15632","article-title":"Impact of different postoperative adjuvant therapies on the survival of early-stage cervical cancer patients with one intermediate-risk factor: a multicenter study of 14 years","volume":"49","author":"Ye","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.annonc.2025.09.003_bib15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s12885-024-12284-9","article-title":"Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.annonc.2025.09.003_bib16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ijrobp.2004.12.029","article-title":"Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size","volume":"62","author":"Ahamad","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.annonc.2025.09.003_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"24","key":"10.1016\/j.annonc.2025.09.003_bib18","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2025.09.003_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13-14","key":"10.1016\/j.annonc.2025.09.003_bib20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/sim.4780131321","article-title":"Stopping when the experimental regimen does not appear to help","volume":"13","author":"Wieand","year":"1994","journal-title":"Stat Med"},{"issue":"20","key":"10.1016\/j.annonc.2025.09.003_bib21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.annonc.2025.09.003_bib22","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1234::AID-CNCR6>3.0.CO;2-K","article-title":"Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes","volume":"80","author":"Samlal","year":"1997","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.annonc.2025.09.003_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bjc.2013.716","article-title":"Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study","volume":"110","author":"Ryu","year":"2014","journal-title":"Br J Cancer"},{"issue":"15","key":"10.1016\/j.annonc.2025.09.003_bib24","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.19.02381","article-title":"Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: a report from the NRG Oncology RTOG 1203 study","volume":"38","author":"Yeung","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annonc.2025.09.003_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2023.05.074","article-title":"Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: a patient reported outcome study of NRG oncology\u2019s RTOG 1203","volume":"175","author":"Konski","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"33","key":"10.1016\/j.annonc.2025.09.003_bib26","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1200\/JCO.20.02530","article-title":"Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial","volume":"39","author":"Chopra","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.annonc.2025.09.003_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamaoncol.2020.7168","article-title":"Effectiveness of sequential chemoradiation vs concurrent chemoradiation or radiation alone in adjuvant treatment after hysterectomy for cervical cancer: the STARS Phase 3 randomized clinical trial","volume":"7","author":"Huang","year":"2021","journal-title":"JAMA Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753425047003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753425047003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:59:40Z","timestamp":1777582780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753425047003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0923753425047003"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2025.09.003","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology\/GOG-263\/KGOG 1008","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}]}}